These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36569931)

  • 21. Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery.
    Hotta-Iwamura C; Benck C; Coley WD; Liu Y; Zhao Y; Quiel JA; Tarbell KV
    J Autoimmun; 2018 Jun; 90():39-48. PubMed ID: 29439835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren's syndrome.
    Keindl M; Davies R; Bergum B; Brun JG; Hammenfors D; Jonsson R; Lyssenko V; Appel S
    Arthritis Res Ther; 2022 May; 24(1):101. PubMed ID: 35526080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2.
    Tsyklauri O; Chadimova T; Niederlova V; Kovarova J; Michalik J; Malatova I; Janusova S; Ivashchenko O; Rossez H; Drobek A; Vecerova H; Galati V; Kovar M; Stepanek O
    Elife; 2023 Jan; 12():. PubMed ID: 36705564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors.
    Kremer J; Henschel P; Simon D; Riet T; Falk C; Hardtke-Wolenski M; Wedemeyer H; Noyan F; Jaeckel E
    Front Immunol; 2022; 13():1005582. PubMed ID: 36618378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.
    Nurieva RI; Zheng S; Jin W; Chung Y; Zhang Y; Martinez GJ; Reynolds JM; Wang SL; Lin X; Sun SC; Lozano G; Dong C
    Immunity; 2010 May; 32(5):670-80. PubMed ID: 20493730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.
    Rosenzwajg M; Salet R; Lorenzon R; Tchitchek N; Roux A; Bernard C; Carel JC; Storey C; Polak M; Beltrand J; Amouyal C; Hartemann A; Corbeau P; Vicaut E; Bibal C; Bougnères P; Tran TA; Klatzmann D
    Diabetologia; 2020 Sep; 63(9):1808-1821. PubMed ID: 32607749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
    Kishimoto TK; Fournier M; Michaud A; Rizzo G; Roy C; Capela T; Nukolova N; Li N; Doyle L; Fu FN; VanDyke D; Traber PG; Spangler JB; Leung SS; Ilyinskii PO
    J Autoimmun; 2023 Nov; 140():103125. PubMed ID: 37844543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T Cells in Systemic Sclerosis.
    Frantz C; Auffray C; Avouac J; Allanore Y
    Front Immunol; 2018; 9():2356. PubMed ID: 30374354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?
    Palomares O; Elewaut D; Irving PM; Jaumont X; Tassinari P
    Allergy; 2022 Nov; 77(11):3293-3308. PubMed ID: 35852798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.
    Do J; Kim D; Kim S; Valentin-Torres A; Dvorina N; Jang E; Nagarajavel V; DeSilva TM; Li X; Ting AH; Vignali DAA; Stohlman SA; Baldwin WM; Min B
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10190-10195. PubMed ID: 28874534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
    J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.
    Kulhankova K; Rouse T; Nasr ME; Field EH
    PLoS One; 2012; 7(9):e43609. PubMed ID: 22984435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
    Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
    Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases.
    Tahvildari M; Dana R
    J Immunol; 2019 Dec; 203(11):2749-2755. PubMed ID: 31740549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.
    Satake A; Schmidt AM; Nomura S; Kambayashi T
    PLoS One; 2014; 9(3):e92888. PubMed ID: 24658577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness.
    Wu D; Li H; Liu M; Qin J; Sun Y
    Nat Commun; 2022 May; 13(1):3021. PubMed ID: 35641500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
    Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
    Front Immunol; 2019; 10():2606. PubMed ID: 31781109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.